IP Library Patent Application 12816827
Patent Application
App. No. 12/816,827

SPINULOSE METAL SURFACES

Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US None
App. No.
12/816,827
Abstract

Spinulose metal surfaces are produced by a modified nanoplasma cyclic deposition process. The unique spinulose surfaces are highly adherent toward polymer and bioactive molecules and cells, including osteoblast, fibroblast and endothelial cells. The nanostructured spinulose surfaces can be coated with a wide range of polymers to form polymer surface coatings that are particularly useful on implants, catheters, guidewires, stents and other medical devices intended for in vivo applications.

Claims (15)

1 . A spinulose surface comprising randomly spaced irregular nanosized thorn-shaped projections on a rounded metal nanoparticulate adhering to a substrate.

2 . The spinulose surface of claim 1 wherein the metal is titanium, zirconium, zirconium/hafnium or mixtures thereof.

3 . The spinulose surface of claim 1 wherein the rounded metal nanoparticulate ranges from about 1 to about 10 um in diameter.

4 . The spinulose surface of claim 3 wherein projections on the nanoparticulate are about 20% of the nanoparticulate diameter.

5 . The spinulose surface of claim 2 further comprising a polymer coating.

6 . The spinulose surface of claim 5 wherein the polymer coating is a poly-L-lactic acid (PLLA), poly-(lactic-co-glycolic acid) (PLGA), or a combination of PLLA and PLGA.

7 . The spinulose surface of claim 2 further comprising a coating of silver/silver oxide.

8 . The spinulose surface of claim 7 further comprising a poly-L-lactic acid (PLLA) coating over the silver/silver oxide.

9 . The spinulose surface of claim 2 further comprising an attached osteoblast, fibroblast or endothelial cell.

10 . The spinulose surface of claim 9 wherein the fibroblast cell is a human periodontal ligament fibroblast cell or a human gingival cell.

11 . The spinulose surface of claim 9 wherein attached cell density is up to at least about 5×10 3 cells/cm 2 .

12 . The spinulose surface of claim 1 which comprises at least a portion of a medical device.

13 . The spinulose surface of claim 12 wherein the medical device is a stent, guidewire, catheter, or electrode.

14 . The spinulose surface of claim 13 wherein the electrode is a miniaturized electrode coated with spinulose titanium.

15 . The spinulose surface of claim 1 wherein the substrate is substrate is a metal, metal alloy, polymer or ceramic, silicone, poly(methylmethacrylate) (PMMA), polyurethane (PU), polyvinyl chloride (PVC), polyethylene terephthalate (PET), polyethylene terephthalate glycol (PETG), polyetheretherketone (PEEK), ultra high molecular weight polyethylene (UHMWPE), or polypropylene (PP), silicon, glass, carbon, salt, titanium, nitinol, CoCrMo or stainless steel.

Assignments (3)
CHANGE OF NAME Recorded Feb 25, 2011
From: NANO SURFACE TECHNOLOGIES LLC
To: METASCAPE LLC
Reel/Frame 025874/0431 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 10, 2010
From: CHAMELEON SCIENTIFIC CORPORATION
To: NANOSURFACE TECHNOLOGIES LLC
Reel/Frame 024816/0401 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 4, 2010
From: THOMAS, CHRISTINA K.; STOREY, DANIEL M.
To: CHAMELEON SCIENTIFIC CORPORATION
Reel/Frame 024788/0581 →